Heart Attack And Stroke Symptoms
Volunteer
Donate
Make a Donation
Memorial Gifts
Monthly Giving
Create a Memorial Page
Start Your Own Fundraiser
Other Ways to Give
Toggle navigation
Login
Login
Cart
Cart
Contact Us
Player size:
small
large
0
0
Concurrent Session III A: Therapeutic Targets in Atherosclerosis
May 6, 2020 11:05am ‐ May 6, 2020 12:20pm
Credits: None available.
Overview
Presentations
CE Information
Comments
Description
Lp(a) in CVD and Aortic Stenosis
Design and Delivery of Microrna Switches to Treat Cardiovascular Diseases
Network-driven Drug Repositioning Unveils a New Anti-atherosclerotic Effect of an Old Compound
Inhibition of MicroRNA-33 Reprograms the Transcriptional Landscape and Kinetic Processes of Immune Cells to Promote Atherosclerotic Plaque Regression
Immune Checkpoint Inhibitors Aggravate T Cell-mediated Plaque Inflammation in Experimental Atherosclerosis
Speaker(s):
Calvin Yeang
Hana Totary-jain
Letizia Amadori
Milessa Afonso
Kikkie Poels
Lp(a) in CVD and Aortic Stenosis
11:05am - 11:25am
Calvin Yeang
Design and Delivery of Microrna Switches to Treat Cardiovascular Diseases
11:35am - 11:45am
Hana Totary-jain
Network-driven Drug Repositioning Unveils a New Anti-atherosclerotic Effect of an Old Compound
11:35am - 11:45am
Letizia Amadori
Inhibition of MicroRNA-33 Reprograms the Transcriptional Landscape and Kinetic Processes of Immune Cells to Promote Atherosclerotic Plaque Regression
11:45am - 11:55am
Milessa Afonso
Immune Checkpoint Inhibitors Aggravate T Cell-mediated Plaque Inflammation in Experimental Atherosclerosis
12:05pm - 12:15pm
Kikkie Poels
×
Credits
Credits: None available.
You must be logged in and own this session in order to post comments.
×
Evaluation
×
Shopping Cart
Item
Price
Remove